Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
and 65% decrease in EGFR
2-dichlorobenzene)
InChi: InChI=1S/C20H34O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h12-13
found more active in cancer cells than in normal healthy cells
950455-15-9
(S,R,S)-AHPC-C2-PEG4-N3 potassium and 65% decrease in EGFR(S, R, S) AHPC C2 PEG4 N3 (VH032 C2 PEG4 N3) is a synthesized E3 ligase ligand linker conjugate that incorporates the (S, R, S) AHPC based VHL ligand and 4 unit PEG linker used in PROTAC technology. (S, R, S) AHPC C2 PEG4 N3 can be used in the synthesis of vRucaparib TP4 (HY 130647). vRucaparib TP4 a highly potent PARP1 degrader with a half maximal degrading concentration (DC50) of 82 nM. Product information Molecular Weight: 703. 85 Formula:
US$ 85.00
US$ 38.00
US$ 38.00
US$ 85.00
US$ 85.00
US$ 35.70
US$ 38.00
US$ 80.00
US$ 38.00
US$ 145.00